FDA Approves First Treatment for ILD With Systemic Sclerosis, Scleroderma

Title: FDA Approves First Treatment for ILD With Systemic Sclerosis, SclerodermaCategory: Health NewsCreated: 9/10/2019 12:00:00 AMLast Editorial Review: 9/10/2019 12:00:00 AM
Source: MedicineNet Arthritis General - Category: Rheumatology Source Type: news